Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 7 of about 7   

Articles published

DVAX 29.41 +0.19 (0.65%)
price chart
7 Small Cap Stocks Holding Low Debt Ratios And Positive Analyst Ratings
Today we screened for smaller companies that have minimal debt, along with positive analyst ratings. When analysts on average favor a company, it signals that a company is doing a variety of things right for itself, which we think warrants further ...
Hepatitis C Drug Companies and All-Oral Treatment: A $20 Billion Market
My main reason for thinking a sustainable stock rebound is possible was because it's a top-ten holding of value-investing legend Seth Klarman, who owns a 9.2% stake in the company (10 million shares) at an average purchase price of $8 per share (30% ...
Interest Rates Going Nowhere, Home Depot CFO Says
Home Depot could issue another $2 billion in debt and still remain below its maximum desired leverage ratio, but Chief Financial Officer Carol Tome said interest rates won't be moving up from their near-historic lows anytime soon, so the company doesn ...
People Moves: September 2012
Dynavax announced the appointment of Christine Larson to the position of vice president and chief financial officer, a newly created position.
Dendreon's Provenge: Early Stage Use
One of the criticisms continually leveled at Dendreon (NASDAQ:DNDN), in articles on Seeking Alpha and elsewhere, in comments to these articles, and in my personal mail, is that the company is doing little if anything to expand Provenge's label to ...
Merck Facing Too Much Competition In HIV Drug Push
Life Technologies Corporation (Pending:LIFE) will actually benefit directly from the increased need for HIV drugs in Africa, as it will collaborate with SATuRN to improve HIV testing.
Apple Inc. (NASDAQ:AAPL) Weekly News Roundup: August 10, 2012
Apple Inc. (NASDAQ:AAPL) extended its rally on Friday, ending last week in positive territory with a gain of about 1% as compared to 5.22% advance in the first week of August.